Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after ...

Pfizer's stock price is down materially from its 2021 highs, but it is also up notably from its April 2025 lows.

Pfizer Inc. Chief Executive Albert Bourla said the company secured a three-year grace period from President Trump’s promised ...

Not just any pharmaceutical stock will do, though. They aren't all created equal. Let's discuss two leaders in the industry ...

The world’s biggest pharma companies recorded their best weekly performance in years on Friday after Pfizer (NYSE:PFE) ...

Of the three highest bidders, Pfizer’s purchase proposal for Metsera was the lowest, regulatory documents reveal. The New ...

The deal on drug prices between the US Administration and Pfizer will leave the margins of innovative pharma companies intact ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

It’s hard to find things that Donald Trump and Bernie Sanders agree on, but one point of consensus is that pharmaceutical ...

Pfizer acquires Metsera for up to $7.3B, aiming to enter the high-growth obesity drug market and diversify its portfolio. Learn more about PFE stock here.

The British pharmaceutical giant has joined the direct-to-consumer push, following Pfizer and Amgen’s announcements in ...